These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11206947)

  • 1. Health values and prospect theory: a comment.
    Stratmann-Schoene D; Klose T
    Med Decis Making; 2001; 21(1):57-9. PubMed ID: 11206947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of patients' values in medicine.
    Llewellyn-Thomas H; Sutherland HJ; Tibshirani R; Ciampi A; Till JE; Boyd NF
    Med Decis Making; 1982; 2(4):449-62. PubMed ID: 7182703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health values and prospect theory.
    Treadwell JR; Lenert LA
    Med Decis Making; 1999; 19(3):344-52. PubMed ID: 10424841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospect theory in the valuation of health.
    Moffett ML; Suarez-Almazor ME
    Expert Rev Pharmacoecon Outcomes Res; 2005 Aug; 5(4):499-505. PubMed ID: 19807267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive validity of prospect theory versus expected utility in health utility measurement.
    Abellan-Perpiñan JM; Bleichrodt H; Pinto-Prades JL
    J Health Econ; 2009 Dec; 28(6):1039-47. PubMed ID: 19833400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a case for using visual analogue scale valuations in cost-utility analysis?
    Parkin D; Devlin N
    Health Econ; 2006 Jul; 15(7):653-64. PubMed ID: 16498700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk attitudes of people with 'manageable' chronic disease: An analysis under prospect theory.
    Rouyard T; Attema A; Baskerville R; Leal J; Gray A
    Soc Sci Med; 2018 Oct; 214():144-153. PubMed ID: 30193175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health outcomes in economic evaluation: who should value health?
    Stamuli E
    Br Med Bull; 2011; 97():197-210. PubMed ID: 21285110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the process of deliberation change individuals' health state valuations? An exploratory study using the person trade-off technique.
    Robinson S; Bryan S
    Value Health; 2013; 16(5):806-13. PubMed ID: 23947974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities.
    Peeters Y; Stiggelbout AM
    Value Health; 2010; 13(2):306-9. PubMed ID: 19744288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-method approach to valuing health states: problems with meaning.
    Nord E; Menzel P; Richardson J
    Health Econ; 2006 Feb; 15(2):215-8. PubMed ID: 16389641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health state valuation methods and reference points: the case of tinnitus.
    Happich M; Moock J; von Lengerke T
    Value Health; 2009; 12(1):88-95. PubMed ID: 19911443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk attitude in gambles with years of life: empirical support for prospect theory.
    Verhoef LC; de Haan AF; van Daal WA
    Med Decis Making; 1994; 14(2):194-200. PubMed ID: 8028473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials?
    Sutherland HJ; da Cunha R; Lockwood GA; Till JE
    Med Decis Making; 1998; 18(1):61-9. PubMed ID: 9456210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The danger of confusing "normal" and "healthy".
    Spaeth GL; Wei H
    Bull Soc Belge Ophtalmol; 2010; (314):5-7. PubMed ID: 20480744
    [No Abstract]   [Full Text] [Related]  

  • 17. Time in health: can we measure individuals' "pure time preferences"?
    Gafni A
    Med Decis Making; 1995; 15(1):31-7. PubMed ID: 7898295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospect theory on the brain? Toward a cognitive neuroscience of decision under risk.
    Trepel C; Fox CR; Poldrack RA
    Brain Res Cogn Brain Res; 2005 Apr; 23(1):34-50. PubMed ID: 15795132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A theoretical framework for TTO valuations of health.
    Buckingham K; Devlin N
    Health Econ; 2006 Oct; 15(10):1149-54. PubMed ID: 16786547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliciting stated health preferences: an application to willingness to pay for longevity.
    Johnson FR; Desvousges WH; Ruby MC; Stieb D; De Civita P
    Med Decis Making; 1998; 18(2 Suppl):S57-67. PubMed ID: 9566467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.